Watton Corey Michael

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 3% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 72%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Watton Corey Michael's trades of Zevra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
405.74
Quantity 98,859 -15.0%
Value US$4,530,644
Transaction date
Purchase
Price
113.14
Quantity 20,317 +5.5%
Value US$3,988,979
Transaction date
Purchase
Price
118.78
Quantity 28,121 -16.9%
Value US$2,917,220
Transaction date
Purchase
Price
5.95
Quantity 275 +37.9%
Value US$1,636
Transaction date
Purchase
Price
5.52
Quantity 325 +81.2%
Value US$1,794
Transaction date
Purchase
Price
5.11
Quantity 400 New position
Value US$2,042
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-10
S Sale
98,859 -15.0%
405.74
US$4,530,644 		98,859 -15.0% 405.74 US$4,530,644
2025-03-31 2025-03-28
B Purchase
20,317 +5.5%
113.14
US$3,988,979 		20,317 +5.5% 113.14 US$3,988,979
2024-10-16 2024-10-11
B Purchase
28,121 -16.9%
118.78
US$2,917,220 		28,121 -16.9% 118.78 US$2,917,220
2023-06-26 2023-06-23
B Purchase
275 +37.9%
5.95
US$1,636 		275 +37.9% 5.95 US$1,636
2023-06-13 2023-06-09
B Purchase
325 +81.2%
5.52
US$1,794 		325 +81.2% 5.52 US$1,794
2023-05-31 2023-05-30
B Purchase
400 New position
5.11
US$2,042 		400 New position 5.11 US$2,042